283 related articles for article (PubMed ID: 4659049)
1. In vivo methods for the assessment of cell-mediated tumor immunity.
Bartlett GL
Natl Cancer Inst Monogr; 1972 Dec; 35():27-32. PubMed ID: 4659049
[No Abstract] [Full Text] [Related]
2. A guinea pig model for tumor immunology. A summary.
Rapp HJ
Isr J Med Sci; 1973 Mar; 9(3):366-74. PubMed ID: 4122812
[No Abstract] [Full Text] [Related]
3. [Immunology and cancer].
Brunner KT
Schweiz Med Wochenschr; 1973 Sep; 103(36):1249-52. PubMed ID: 4584090
[No Abstract] [Full Text] [Related]
4. Secondary cytotoxic tumor immune response induced in vitro.
Röllinghoff M
J Immunol; 1974 May; 112(5):1718-25. PubMed ID: 4544796
[No Abstract] [Full Text] [Related]
5. Lymphocyte transfer factor.
Thompson RB
Rev Eur Etud Clin Biol; 1971 Mar; 16(3):201-4. PubMed ID: 4397550
[No Abstract] [Full Text] [Related]
6. The present status of tumor immunology.
Fisher B
Adv Surg; 1971; 5():189-254. PubMed ID: 4941820
[No Abstract] [Full Text] [Related]
7. [Immunotherapy of neoplasms].
Trepel F
Med Klin; 1971 Feb; 66(7):222-9. PubMed ID: 4324109
[No Abstract] [Full Text] [Related]
8. Effects on tumor growth in vivo by manipulation of the tumor immune response.
Sjögren HO
Johns Hopkins Med J Suppl; 1974; 3():51-60. PubMed ID: 4370816
[No Abstract] [Full Text] [Related]
9. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
McKenzie IF; Snell GD
Transplant Proc; 1973 Mar; 5(1):953-6. PubMed ID: 4572155
[No Abstract] [Full Text] [Related]
10. Cell-mediated immunity.
Valentine FT; Lawrence HS
Adv Intern Med; 1971; 17():51-93. PubMed ID: 4147307
[No Abstract] [Full Text] [Related]
11. Influence of preexisting tumor immunity on Bacillus Calmette-Guérin immunotherapy of guinea pigs with both regional and disseminated tumor.
Jessup JM; Riggs CW; Hanna MG
Cancer Res; 1977 Aug; 37(8 Pt 1):2565-73. PubMed ID: 872084
[No Abstract] [Full Text] [Related]
12. [Disturbance of immune surveillance in tumor-bearing host (author's transl)].
Haba S; Kitagawa M
Tanpakushitsu Kakusan Koso; 1974 Sep; 19(10):930-8. PubMed ID: 4612620
[No Abstract] [Full Text] [Related]
13. Cytophilic antibody as an auxiliary factor in cell-mediated immunity.
Ptak W
Allerg Immunol (Leipz); 1973; 19(2-4):290-6. PubMed ID: 4375939
[No Abstract] [Full Text] [Related]
14. Dynamics of immunologic enhancement.
Kaliss N
Transplant Proc; 1970 Mar; 2(1):59-67. PubMed ID: 4940355
[No Abstract] [Full Text] [Related]
15. An experimental model for immunotherapy of cancer.
Zbar B; Ribi E; Rapp HJ
Natl Cancer Inst Monogr; 1973 Dec; 39():3-9. PubMed ID: 4595326
[No Abstract] [Full Text] [Related]
16. Lymphocyte-mediated immune responses in neoplasia.
Pilch YH; Golub SH
Am J Clin Pathol; 1974 Aug; 62(2):184-211. PubMed ID: 4602086
[No Abstract] [Full Text] [Related]
17. Tumor-specific antigens: detection by local transfer of delayed skin hypersensitivity.
Kronman BS; Rapp HJ; Borsos T
J Natl Cancer Inst; 1969 Oct; 43(4):869-75. PubMed ID: 4310097
[No Abstract] [Full Text] [Related]
18. Role of activated macrophages in nonspecific resistance to neoplasia.
Hibbs JB
J Reticuloendothel Soc; 1976 Sep; 20(3):223-31. PubMed ID: 789879
[No Abstract] [Full Text] [Related]
19. Clinical aspects of cancer immunity.
Moore GE
Prog Clin Cancer; 1973; 5():107-20. PubMed ID: 4571116
[No Abstract] [Full Text] [Related]
20. The gordian knot of tumour immunology.
Amlot P
Guys Hosp Rep; 1974; 123(1):43-51. PubMed ID: 4549511
[No Abstract] [Full Text] [Related]
[Next] [New Search]
